Investigating how vaping affects nicotine and its safety
Effects of vaping-induced oxidation on nicotine analogs e-cigarettes
This study looks at how vaping changes the makeup of nicotine products, especially a new type called 6-methyl nicotine, to see how it affects the health and addiction risks for teens and young adults, helping to find ways to keep people safer from vaping's dangers.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-11119068 on NIH RePORTER |
What this research studies
This research explores the impact of vaping on the chemical composition of nicotine products, particularly focusing on a new form of nicotine called 6-methyl nicotine. It aims to understand how vaping alters the toxicity and addictive properties of these substances, especially among adolescents and young adults. By analyzing the aerosol produced from vaping devices, the study seeks to identify harmful compounds that may pose health risks. The findings could inform regulatory measures and public health strategies to mitigate the dangers associated with vaping.
Who could benefit from this research
Good fit: Ideal candidates for this research include adolescents and young adults who currently use or have used vaping products.
Not a fit: Patients who do not use vaping products or are not interested in nicotine-related research may not benefit from this study.
Why it matters
Potential benefit: If successful, this research could lead to safer vaping products and better public health guidelines for young users.
How similar studies have performed: Previous research has indicated significant health risks associated with vaping, but this specific investigation into 6-methyl nicotine is relatively novel.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Corteselli, Elizabeth Marie — Univ of North Carolina Chapel Hill
- Study coordinator: Corteselli, Elizabeth Marie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.